NEW YORK (GenomeWeb) – Quidel reported after the close of the market on Wednesday that its third quarter revenues rose 3 percent year over year.

For the three months ended Sept. 30, revenues increased to $50.9 million from $49.3 million in Q3 2016, beating the average analyst expectation for revenues of $50.3 million.

In the prior-year quarter, Quidel received a final milestone-based cash payment of $3.8 million dollars from the Bill and Melinda Gates Foundation. Excluding that amount, revenues increased by 12 percent and were driven by immunoassay sales, the firm said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.